PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsMC2 Therapeutics
MC2 Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
WynzoraBetamethasone, Calcipotriene2020-07-202027-2039
Psoriasis
,
Atopic dermatitis
,
Pruritus ani
,
Inflammation
,
Facial dermatoses
,
Seborrheic dermatitis
,
Foot dermatoses
,
Hand dermatoses
,
Scalp dermatoses
,
Leg dermatoses
,
Mycoses
,
Oral candidiasis
,
Vulvovaginal candidiasis
,
Tinea pedis
,
Cutaneous candidiasis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Betamethasone
psoriasis
Calcipotriene
psoriasis
Betamethasone dipropionate
psoriasis
Bos taurus adrenal cortex corticosteroids
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
uveitis
,
leukemia
,
neoplasms
,
respiratory insufficiency
,
pneumonia
,
giant cell arteritis
,
polymyalgia rheumatica
,
lupus nephritis
,
multiple myeloma
,
breast neoplasms
,
stomatitis
,
oral ulcer
,
animal mammary neoplasms
,
ornithine carbamoyltransferase deficiency disease
,
covid-19
,
arteritis
,
tendinopathy
,
sarcoidosis
,
pulmonary sarcoidosis
,
b-cell chronic lymphocytic leukemia
,
hypersensitivity
,
myositis
,
healthy volunteers/patients
,
prurigo
,
nephritis
,
proteinuria
,
systemic lupus erythematosus
,
prostatic neoplasms
,
urogenital neoplasms
,
male genital neoplasms
,
hematopoietic stem cell transplantation
,
bronchiolitis obliterans syndrome
,
vasculitis
,
granulomatosis with polyangiitis
,
anti-neutrophil cytoplasmic antibody-associated vasculitis
,
microscopic polyangiitis
,
obstructive lung diseases
,
lung diseases
,
graft rejection
,
thrombocytopenic purpura idiopathic
,
psychology rejection
,
thrombocytopenia
,
lymphoma
,
hemorrhage
,
heart diseases
,
nephrotic syndrome
,
syndrome
,
nephrosis
,
osteoporosis
,
follicular lymphoma
,
kidney transplantation
,
asthma
,
chronic obstructive pulmonary disease
,
liver transplantation
,
graft vs host disease
,
atopic dermatitis
,
eczema
,
dermatitis
,
renal insufficiency
,
chronic kidney failure
,
kidney diseases
,
infections
,
cytomegalovirus infections
,
communicable diseases
,
heart transplantation
,
multiple sclerosis
,
sclerosis
,
chronic renal insufficiency
,
renal dialysis
,
renal replacement therapy
,
drug-related side effects and adverse reactions
,
fatigue
,
relapsing-remitting multiple sclerosis
,
cystic fibrosis
,
allergic bronchopulmonary aspergillosis
,
transplantation
,
liver diseases
,
end stage liver disease
,
emergencies
,
disease progression
,
psoriasis
Daivonex
psoriasis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use